XML 80 R69.htm IDEA: XBRL DOCUMENT v3.5.0.2
Condensed Consolidating Financial Information (Details 3) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Cash Flow from Operating Activities:    
Net cash provided by operating activities $ (11,758) $ 111,164
Cash Flow from Investing Activities:    
Acquisition of SoberLink, cash consideration 0 (24,402)
Proceeds from sale of property and equipment 68 49
Insurance proceeds - damaged property 4,733 1,270
Acquisition of LCS, cash consideration 0 (307,403)
Change in restricted cash and investments (97,716) (11,136)
Capital expenditures (68,015) (100,844)
Net cash used in investing activities (160,930) (442,466)
Cash Flow from Financing Activities:    
Proceeds from long-term debt 813,077 642,000
Payments on long-term debt (775,256) (222,675)
Payments on non-recourse debt (1,878) (6,366)
Proceeds from non-recourse debt 273,087 70,117
Taxes paid related to net share settlements of equity awards (2,336) (2,748)
Proceeds from issuance of common stock in connection with ESPP 338 321
Debt issuance costs (20,490) (5,217)
Income tax (deficiency) benefit related to equity compensation (844) 1,252
Proceeds from the exercise of stock options 2,367 2,513
Cash dividends paid (145,991) (138,454)
Net cash provided by financing activities 142,074 340,743
Effect of Exchange Rate Changes on Cash and Cash Equivalents 1,099 (3,647)
Net (Decrease) Increase in Cash and Cash Equivalents (29,515) 5,794
Cash and Cash Equivalents, beginning of period 59,638 41,337
Cash and Cash Equivalents, end of period 30,123 47,131
The GEO Group, Inc.    
Cash Flow from Operating Activities:    
Net cash provided by operating activities 99,124 72,063
Cash Flow from Investing Activities:    
Acquisition of SoberLink, cash consideration  
Proceeds from sale of property and equipment 68 0
Insurance proceeds - damaged property 4,733 0
Acquisition of LCS, cash consideration   (307,403)
Change in restricted cash and investments (24) 101
Capital expenditures (9,879) (51,084)
Net cash used in investing activities (5,102) (358,386)
Cash Flow from Financing Activities:    
Proceeds from long-term debt 813,077 642,000
Payments on long-term debt (775,256) (222,675)
Payments on non-recourse debt 0 0
Proceeds from non-recourse debt 0 0
Taxes paid related to net share settlements of equity awards (2,336) (2,748)
Proceeds from issuance of common stock in connection with ESPP 0 321
Debt issuance costs (16,980)
Income tax (deficiency) benefit related to equity compensation (844) 1,252
Proceeds from the exercise of stock options 2,367 2,513
Cash dividends paid (145,991) (138,454)
Net cash provided by financing activities (125,963) 282,209
Effect of Exchange Rate Changes on Cash and Cash Equivalents 0 0
Net (Decrease) Increase in Cash and Cash Equivalents (31,941) (4,114)
Cash and Cash Equivalents, beginning of period 37,077 18,492
Cash and Cash Equivalents, end of period 5,136 14,378
Combined Subsidiary Guarantors    
Cash Flow from Operating Activities:    
Net cash provided by operating activities 57,187 74,464
Cash Flow from Investing Activities:    
Acquisition of SoberLink, cash consideration   (24,402)
Proceeds from sale of property and equipment 0 49
Insurance proceeds - damaged property 0 1,270
Acquisition of LCS, cash consideration  
Change in restricted cash and investments (2,635) (1,957)
Capital expenditures (54,552) (47,833)
Net cash used in investing activities (57,187) (72,873)
Cash Flow from Financing Activities:    
Proceeds from long-term debt 0 0
Payments on long-term debt 0
Payments on non-recourse debt 0 0
Proceeds from non-recourse debt 0 0
Taxes paid related to net share settlements of equity awards 0 0
Proceeds from issuance of common stock in connection with ESPP 0
Debt issuance costs 0 0
Income tax (deficiency) benefit related to equity compensation 0 0
Proceeds from the exercise of stock options 0 0
Cash dividends paid 0
Net cash provided by financing activities 0 0
Effect of Exchange Rate Changes on Cash and Cash Equivalents 0 0
Net (Decrease) Increase in Cash and Cash Equivalents 0 1,591
Cash and Cash Equivalents, beginning of period 0 782
Cash and Cash Equivalents, end of period 0 2,373
Combined Non-Guarantor Subsidiaries    
Cash Flow from Operating Activities:    
Net cash provided by operating activities (168,069) (35,363)
Cash Flow from Investing Activities:    
Acquisition of SoberLink, cash consideration  
Proceeds from sale of property and equipment 0 0
Insurance proceeds - damaged property 0 0
Acquisition of LCS, cash consideration   0
Change in restricted cash and investments (95,057) (9,280)
Capital expenditures (3,584) (1,927)
Net cash used in investing activities (98,641) (11,207)
Cash Flow from Financing Activities:    
Proceeds from long-term debt 0 0
Payments on long-term debt 0 0
Payments on non-recourse debt (1,878) (6,366)
Proceeds from non-recourse debt 273,087 70,117
Taxes paid related to net share settlements of equity awards 0 0
Proceeds from issuance of common stock in connection with ESPP 338 0
Debt issuance costs (3,510) (5,217)
Income tax (deficiency) benefit related to equity compensation 0 0
Proceeds from the exercise of stock options 0 0
Cash dividends paid 0 0
Net cash provided by financing activities 268,037 58,534
Effect of Exchange Rate Changes on Cash and Cash Equivalents 1,099 (3,647)
Net (Decrease) Increase in Cash and Cash Equivalents 2,426 8,317
Cash and Cash Equivalents, beginning of period 22,561 22,063
Cash and Cash Equivalents, end of period $ 24,987 $ 30,380